Posted By: Magda Yang
Mon Apr 6th, 2020
AABB recently launched a new website to share information with the public, blood collectors and clinicians about convalescent plasma from individuals who have recovered from COVID-19 (CCP). FDA recently announced new guidelines permitting the use of CCP as an investigational treatment for patients
